Table 1.
Baseline | 12 Months | |||||
---|---|---|---|---|---|---|
All n=58 |
LYX n=23 |
Placebo Comparison Group n=35 |
All | LYX | Placebo Comparison Group | |
Vitamin A, % RDA | ||||||
Diet | 165 [46 – 500] | 163 [70 – 296] | 176 [46 – 500] | 128 [44 – 438]* | 126 [61 – 337] | 131 [44 – 438]* |
Supplement | 555 [0 – 1284] | 548 [0 – 1284] | 616 [130 – 1232] | 456 [0 – 1235] | 492 [130 – 840] | 420 [0 – 1235] |
Total | 723 [105 – 1722] | 718 [105 – 1442] | 765 [315 – 1722] | 673 [120 – 1462]* | 676 [211 – 1168] | 654 [120 – 1462]* |
Vitamin D, % RDA | ||||||
Diet | 44 [12 – 171] | 46 [22 – 171] | 41 [12 – 111] | 37 [9 – 136] | 38 [9 – 112] | 36 [11 – 136] |
Supplement | 133 [44 – 1500] | 133 [67 – 1433] | 133 [44 – 1500] | 167 [0 – 1500] | 167 [67 – 333] | 167 [0 – 1500] |
Total | 195 [71 – 1611] | 194 [92 – 1477] | 196 [71 – 1611] | 207 [30 – 1624] | 207 [87 – 409] | 207 [30 – 1624] |
Vitamin E, % RDA | ||||||
Diet | 88 [27 – 893] | 86 [50 – 247] | 89 [27 – 893] | 71 [31 – 574] | 71 [48 – 255] | 71 [31 – 574] |
Supplement | 1619 [0 – 3810] | 1273 [0 – 3810] | 1818 [182 – 3810] | 1273 [0 – 3111] | 1212 [182 – 2424] | 1905 [0 – 3111] |
LXS/Placebo | 0 | 0 | 0 | 72 [3 – 160] | 100 [3 – 160]§ | 56 [12 – 89]§ |
Total | 1851 [62 – 4703] | 1345 [62 – 3910] | 1896 [350 – 4703] | 1494 [71 – 3178] | 1302 [331 – 2660] | 2025 [71 – 3178] |
Vitamin K, % AI | ||||||
Diet | 95 [27 – 397] | 95 [55 – 252] | 87 [27 – 397] | 96 [30 – 1233] | 117 [47 – 1233] | 85 [30 – 285] |
Supplement | 500 [0 – 9404] | 500 [0 – 3000] | 667 [0 – 9404] | 1333 [0 – 9455] | 1067 [0 – 2667]§ | 2333 [0 – 9454]§ |
Total | 689 [63 – 9535] | 578 [63 – 3094] | 1064 [85 – 9535] | 1430 [43 – 9593] | 1292 [125 – 2797]§ | 2395 [43 – 9593]§ |
RDA: Recommended Daily Allowance; AI: Adequate Intake
p<0.05, the difference between baseline and 12 months within each group (all, LXS, or placebo);
p<0.05 for the difference between LXS and comparison group at 12 month
Note: LXS and comparison intakes are adjusted for adherence